Loading provider…
Loading provider…
Radiation Oncology Physician in Cleveland, OH
NPI: 1386658656Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Samuel's Phone Numberphone_androidMobile
Get M.D. Samuel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
MI State Medical License
2024 - 2027
OH State Medical License
2001 - 2027
IL State Medical License
2024 - 2026
KY State Medical License
2024 - 2026
WV State Medical License
2024 - 2026
IN State Medical License
2024 - 2025

American Board of Radiology
Radiation Oncology
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 2001
Cleveland Clinic Foundation
Residency • Radiation Oncology
2001 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77334Design and construction of complex radiation treatment device | 112 | 604 |
| 2 | 77263Complex radiation therapy planning | 102 | 121 |
| 3 | 77300Calculation of radiation therapy dose | 89 | 765 |
| 4 | 772953d radiation therapy planning | 60 | 75 |
| 5 | 77432Stereotactic radiation treatment management of brain lesions, complete course of treatment consisting of 1 session | 51 | 65 |
Authors: Nathan Pennell, Gene Barnett, John Suh, Vineeth Tatineni, Pradnya Patil, Manmeet Ahluwalia, Rupesh Kotecha
Journal: Sci Rep
Publication Date: 2022-01-17
The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
Authors: Zachary Mayo, John Suh
Journal: Neuro Oncol
Relationship between HER2 status and prognosis in women with brain metastases from breast cancer.
Authors: Michael Vogelbaum, Gene Barnett, Robert Weil, Nicholas Marko
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2011-10-22
Lead Sponsor: Case Comprehensive Cancer Center
Intervention / Treatment: DRUG: 18F-fluciclovine, DEVICE: PET/CT of the brain
Lead Sponsor: Case Comprehensive Cancer Center
Intervention / Treatment: PROCEDURE: quality-of-life assessment, RADIATION: stereotactic radiosurgery, PROCEDURE: cognitive assessment
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Radiation Therapy Oncology Group
Intervention / Treatment: OTHER: Placebo, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Bevacizumab, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: 3-Dimensional Conformal Radiation Therapy